{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:39:30Z","timestamp":1788910770871,"version":"build-2803163510"},"reference-count":19,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2020,5,25]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Globally, non-steroidal anti-inflammatory drugs (NSAIDs) are highly used to treat pain. With the rise of the COVID-19 pandemic, the safety of NSAIDs use has been called into question. These concerns are worthy of review. At present, there is no compelling data showing that NSAIDs worsen the severity of COVID-19 symptoms or increase one\u2019s likelihood of contracting the illness. For patients in pain and without symptoms that could potentially be attributed to COVID-19 (cough, fevers\/chills, lethargy, myalgias, anosmia and so on), NSAIDs should continue to remain a viable option to provide analgesia to patients in need.<\/jats:p>","DOI":"10.1136\/rapm-2020-101584","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T05:56:59Z","timestamp":1591250219000},"page":"677-678","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["NSAIDs for analgesia in the era of COVID-19"],"prefix":"10.1136","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7718-0052","authenticated-orcid":false,"given":"Daniel L","family":"Herzberg","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Detroit Medical Center\/Wayne State University, Detroit, Michigan, USA"},{"name":"Department of Emergency Medicine, MedStar Georgetown University Hospital, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry P","family":"Sukumaran","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Detroit Medical Center\/Wayne State University, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-4396","authenticated-orcid":false,"given":"Eugene","family":"Viscusi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"2025101109520952000_45.9.677.1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J Pharm Pharm Sci"},{"key":"2025101109520952000_45.9.677.2","doi-asserted-by":"publisher","DOI":"10.2165\/11539430-000000000-00000"},{"key":"2025101109520952000_45.9.677.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8"},{"key":"2025101109520952000_45.9.677.4","doi-asserted-by":"crossref","unstructured":"Wan Y , Shang J , Graham R , et al . Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020;94.doi:10.1128\/JVI.00127-20","DOI":"10.1128\/JVI.00127-20"},{"key":"2025101109520952000_45.9.677.5","unstructured":"Krietsch Boerner L . No evidence to support link between ibuprofen and COVID-19, experts say. Chemical & Engineering News, 2020. Available: https:\/\/cen.acs.org\/pharmaceuticals\/evidence-support-link-between-ibuprofen\/98\/web\/2020\/03"},{"key":"2025101109520952000_45.9.677.6","unstructured":"@olivierveran . La prise d'anti-inflammatoires (ibuprof\u00e8ne, cortisone) pourrait \u00eatre un facteur d'aggravation de l\u2019infection. En cas de fi\u00e8vre, prenez du parac\u00e9tamol. Si vous \u00eates d\u00e9j sous anti-inflammatoires ou en cas de doute, demandez conseil votre m\u00e9decin.\u201d Twitter, 2020. Available: https:\/\/twitter.com\/olivierveran\/status\/1238776545398923264"},{"key":"2025101109520952000_45.9.677.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1168"},{"key":"2025101109520952000_45.9.677.8","unstructured":"ScienceAlert . Updated: WHO now doesn\u2019t recommend avoiding ibuprofen for COVID-19 symptoms, 2020. Available: https:\/\/www.sciencealert.com\/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms"},{"key":"2025101109520952000_45.9.677.9","unstructured":"European Medicines Agency . Ema gives advice on the use of non-steroidal anti-inflammatories for COVID-19, 2020. Available: https:\/\/www.ema.europa.eu\/en\/news\/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19"},{"key":"2025101109520952000_45.9.677.10","unstructured":"Food and Drug Administration . Fda advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19, 2020. Available: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19"},{"key":"2025101109520952000_45.9.677.11","doi-asserted-by":"crossref","unstructured":"World Health Organization . The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19, 2020. Available: https:\/\/www.who.int\/news-room\/commentaries\/detail\/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19","DOI":"10.15557\/PiMR.2020.0022"},{"key":"2025101109520952000_45.9.677.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1185"},{"key":"2025101109520952000_45.9.677.13","unstructured":"Sodhi M , Etminan M . Safety of ibuprofen in patients with COVID-19; causal or confounded? Chest 2020:pii: S0012-3692(20)30572-9."},{"key":"2025101109520952000_45.9.677.14","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2014.577"},{"key":"2025101109520952000_45.9.677.15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.chest.2016.11.012","article-title":"Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb\/III Trial","volume":"151","author":"Hung","year":"2017","journal-title":"Chest"},{"key":"2025101109520952000_45.9.677.16","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s12325-020-01321-1","article-title":"Warning against the use of anti-inflammatory medicines to cure COVID-19: building Castles in the air","volume":"37","author":"Varrassi","year":"2020","journal-title":"Adv Ther"},{"key":"2025101109520952000_45.9.677.17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0022-3565(25)38847-6","article-title":"Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates","volume":"269","author":"Pacifici","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"2025101109520952000_45.9.677.18","doi-asserted-by":"publisher","DOI":"10.1007\/BF02532379"},{"key":"2025101109520952000_45.9.677.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.aat.2011.08.003"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2020-101584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T16:52:21Z","timestamp":1760201541000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2020-101584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,8,20]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/rapm-2020-101584"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2020-101584","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]}}}